Neuronal uptake of nanoformulated superoxide dismutase and attenuation of angiotensin II-dependent hypertension after central administration

Free Radical Biology and Medicine

Volumn 73, Issue , 2014, Pages 299-307

  Savalia, Krupa ^a   Manickam, Devika S ^b   Rosenbaugh, Erin G ^a   Tian, Jun ^a   Ahmad, Iman M ^a   Kabanov, Alexander V ^b   Zimmerman, Matthew C ^a,c  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Angiotensin II; Free radicals; Hypertension; Nanomedicine; Neurons; Superoxide; Superoxide dismutase

Indexed keywords

ANGIOTENSIN II; ANTIHYPERTENSIVE AGENT; COPOLYMER; COPPER ZINC SUPEROXIDE DISMUTASE; MACROGOL; POLYLYSINE; SUPEROXIDE; ANTIOXIDANT; MACROGOL DERIVATIVE; NANOPARTICLE; POLYMER; SCAVENGER; SUPEROXIDE DISMUTASE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CELL SURVIVAL; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; ELECTRON SPIN RESONANCE; ELEVATED BLOOD PRESSURE; ENZYME ACTIVITY; HYPERTENSION; IN VIVO STUDY; MALE; MOUSE; NANOMEDICINE; NERVE CELL CULTURE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; ANIMAL; C57BL MOUSE; CELL CULTURE; CENTRAL NERVOUS SYSTEM; HEART FAILURE; METABOLISM;

ANGIOTENSIN II; ANIMALS; ANTIOXIDANTS; CELLS, CULTURED; CENTRAL NERVOUS SYSTEM; DRUG DELIVERY SYSTEMS; ELECTRON SPIN RESONANCE SPECTROSCOPY; FREE RADICAL SCAVENGERS; HEART FAILURE; HYPERTENSION; MALE; MICE; MICE, INBRED C57BL; NANOPARTICLES; POLYETHYLENE GLYCOLS; POLYMERS; SUPEROXIDE DISMUTASE; SUPEROXIDES;

EID: 84903128060     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2014.06.001     Document Type: Article

References (52)

1. SH Chan, KS Hsu, CC Huang, LL Wang, CC Ou, and JY. Chan NADPH oxidase-derived superoxide anion mediates angiotensin II-induced pressor effect via activation of p38 mitogen-activated protein kinase in the rostral ventrolateral medulla Circ. Res. 97 2005 772 780 (Pubitemid 41447127)
2. MC Zimmerman, RP Dunlay, E Lazartigues, Y Zhang, RV Sharma, JF Engelhardt, and RL. Davisson Requirement for Rac1-dependent NADPH oxidase in the cardiovascular and dipsogenic actions of angiotensin II in the brain Circ. Res. 95 2004 532 539 (Pubitemid 39180933)
3. MC Zimmerman, and RL. Davisson Redox signaling in central neural regulation of cardiovascular function Prog. Biophys. Mol. Biol. 84 2004 125 149 (Pubitemid 38215209)
4. M Nozoe, Y Hirooka, Y Koga, S Araki, S Konno, T Kishi, T Ide, and K. Sunagawa Mitochondria-derived reactive oxygen species mediate sympathoexcitation induced by angiotensin II in the rostral ventrolateral medulla J. Hypertens. 26 2008 2176 2184
5. JX Yin, RF Yang, S Li, AO Renshaw, YL Li, HD Schultz, and MC. Zimmerman Mitochondria-produced superoxide mediates angiotensin II-induced inhibition of neuronal potassium current Am. J. Physiol. Cell Physiol 298 2010 C857 C865
6. VL Roger, AS Go, and DM. Lloyd-Jones Heart disease and stroke statistics - 2012 update: a report from the American Heart Association Circulation 125 2012 e2 e220
7. AL Valderrama, C Gillespie, S Coleman King, MG George, and Y. Hong Vital signs: awareness and treatment of uncontrolled hypertension among adults - United States, 2003-2010 MMWR 61 2012 703 709
8. JB. Simpson The circumventricular organs and the central actions of angiotensin Neuroendocrinology 32 1981 248 256 (Pubitemid 11134024)
9. MC Zimmerman, RV Sharma, and RL. Davisson Superoxide mediates angiotensin II-induced influx of extracellular calcium in neural cells Hypertension 45 2005 717 723 (Pubitemid 40418371)
10. 2+ currents: intracellular mechanisms Am. J. Physiol. 271 1996 C154 C163
11. A San Martin, and KK. Griendling Redox control of vascular smooth muscle migration Antioxid. Redox Signaling 12 2010 625 640
12. RM. Touyz Reactive oxygen species and angiotensin II signaling in vascular cells - implications in cardiovascular disease Braz. J. Med. Biol. Res. 37 2004 1263 1273 (Pubitemid 39172561)
13. RM Touyz, F Tabet, and EL. Schiffrin Redox-dependent signalling by angiotensin II and vascular remodelling in hypertension Clin. Exp. Pharmacol. Physiol. 30 2003 860 866 (Pubitemid 37506154)
14. PJ Marvar, SR Thabet, TJ Guzik, HE Lob, LA McCann, C Weyand, FJ Gordon, and DG. Harrison Central and peripheral mechanisms of T-lymphocyte activation and vascular inflammation produced by angiotensin II-induced hypertension Circ. Res. 107 2010 263 270
15. DG Harrison, PJ Marvar, and JM. Titze Vascular inflammatory cells in hypertension Front. Physiol 3 2012 128
16. B Lassegue, and KK. Griendling NADPH oxidases: functions and pathologies in the vasculature Arterioscler. Thromb. Vasc. Biol. 30 2010 653 661
17. RM. Touyz Oxidative stress and vascular damage in hypertension Curr. Hypertens. Rep. 2 2000 98 105
18. SH Chan, MH Tai, CY Li, and JY. Chan Reduction in molecular synthesis or enzyme activity of superoxide dismutases and catalase contributes to oxidative stress and neurogenic hypertension in spontaneously hypertensive rats Free Radic. Biol. Med. 40 2006 2028 2039 (Pubitemid 43728865)
19. MC Zimmerman, E Lazartigues, RV Sharma, and RL. Davisson Hypertension caused by angiotensin II infusion involves increased superoxide production in the central nervous system Circ. Res. 95 2004 210 216 (Pubitemid 38988688)
20. TE Lindley, MF Doobay, RV Sharma, and RL. Davisson Superoxide is involved in the central nervous system activation and sympathoexcitation of myocardial infarction-induced heart failure Circ. Res. 94 2004 402 409 (Pubitemid 38240733)
21. M Yin, MD Wheeler, HD Connor, Z Zhong, H Bunzendahl, A Dikalova, RJ Samulski, R Schoonhoven, RP Mason, JA Swenberg, and RG. Thurman Cu/Zn-superoxide dismutase gene attenuates ischemia-reperfusion injury in the rat kidney J. Am. Soc. Nephrol. 12 2001 2691 2700 (Pubitemid 33115416)
22. MC Zimmerman, E Lazartigues, JA Lang, P Sinnayah, IM Ahmad, DR Spitz, and RL. Davisson Superoxide mediates the actions of angiotensin II in the central nervous system Circ. Res. 91 2002 1038 1045 (Pubitemid 35416641)
23. EG Rosenbaugh, JW Roat, L Gao, RF Yang, DS Manickam, JX Yin, HD Schultz, TK Bronich, EV Batrakova, AV Kabanov, IH Zucker, and MC. Zimmerman The attenuation of central angiotensin II-dependent pressor response and intra-neuronal signaling by intracarotid injection of nanoformulated copper/zinc superoxide dismutase Biomaterials 31 2010 5218 5226
24. Y Ding, YL Li, MC Zimmerman, RL Davisson, and HD. Schultz Role of CuZn superoxide dismutase on carotid body function in heart failure rabbits Cardiovasc. Res. 81 2009 678 685
25. YJ Woo, JC Zhang, C Vijayasarathy, RM Zwacka, JF Englehardt, TJ Gardner, and HL. Sweeney Recombinant adenovirus-mediated cardiac gene transfer of superoxide dismutase and catalase attenuates postischemic contractile dysfunction Circulation 98 19 Suppl. 1998 II255 II260 (discussion II260-II261)
26. LC Costantini, JC Bakowska, XO Breakefield, and O. Isacson Gene therapy in the CNS Gene Ther 7 2000 93 109 (Pubitemid 30088955)
27. R Alemany, K Suzuki, and DT. Curiel Blood clearance rates of adenovirus type 5 in mice J. Gen. Virol. 81 Pt 11 2000 2605 2609
28. D Descamps, and K. Benihoud Two key challenges for effective adenovirus-mediated liver gene therapy: innate immune responses and hepatocyte-specific transduction Curr. Gene Ther. 9 2009 115 127
29. DS Manickam, AM Brynskikh, JL Kopanic, PL Sorgen, NL Klyachko, EV Batrakova, TK Bronich, and AV. Kabanov Well-defined cross-linked antioxidant nanozymes for treatment of ischemic brain injury J. Controlled Release 162 2012 636 645
30. Klyachko NL, Haney MJ, Zhao Y, Manickam DS, Mahajan V, Suresh P, Hingtgen SD, Mosley RL, Gendelman HE, Kabanov AV, Batrakova EV. Macrophages offer a paradigm switch for CNS delivery of therapeutic proteins. Nanomedicine (London), http://dx.doi.org/10.2217/NNM.13.115, in press.
31. NL Klyachko, DS Manickam, AM Brynskikh, SV Uglanova, S Li, SM Higginbotham, TK Bronich, EV Batrakova, and AV. Kabanov Cross-linked antioxidant nanozymes for improved delivery to CNS Nanomedicine 8 2012 119 129
32. C Sun, C Sumners, and MK. Raizada Chronotropic action of angiotensin II in neurons via protein kinase C and CaMKII Hypertension 39 2 Pt 2 2002 562 566 (Pubitemid 34165183)
33. C Sun, J Du, MK Raizada, and C. Sumners Modulation of delayed rectifier potassium current by angiotensin II in CATH.a cells Biochem. Biophys. Res. Commun. 310 2003 710 714 (Pubitemid 37188677)
34. M Zhu, CH Gelband, P Posner, and C. Sumners Angiotensin II decreases neuronal delayed rectifier potassium current: role of calcium/calmodulin- dependent protein kinase II J. Neurophysiol. 82 1999 1560 1568 (Pubitemid 29439717)
35. NL Klyachko, DS Manickam, AM Brynskikh, SV Uglanova, S Li, SM Higginbotham, TK Bronich, EV Batrakova, and AV. Kabanov Cross-linked antioxidant nanozymes for improved delivery to CNS Nanomedicine 8 2012 119 129
36. DS Manickam, AM Brynskikh, JL Kopanic, PL Sorgen, NL Klyachko, EV Batrakova, TK Bronich, and AV. Kabanov Well-defined cross-linked antioxidant nanozymes for treatment of ischemic brain injury J. Controlled Release 162 2012 636 645
37. EB Oliveira-Sales, DS Colombari, RL Davisson, S Kasparov, AE Hirata, RR Campos, and JF. Paton Kidney-induced hypertension depends on superoxide signaling in the rostral ventrolateral medulla Hypertension 56 2010 290 296
38. VM Campese, Y Shaohua, and Z. Huiquin Oxidative stress mediates angiotensin II-dependent stimulation of sympathetic nerve activity Hypertension 46 2005 533 539 (Pubitemid 41376834)
39. EG Rosenbaugh, KK Savalia, DS Manickam, and MC. Zimmerman Antioxidant-based therapies for angiotensin II-associated cardiovascular diseases Am. J. Physiol. Regul. Integr. Comp. Physiol 304 2013 R917 R928
40. DG Harrison, TJ Guzik, HE Lob, MS Madhur, PJ Marvar, SR Thabet, A Vinh, and CM. Weyand Inflammation, immunity, and hypertension Hypertension 57 2011 132 140
41. PJ Marvar, H Lob, A Vinh, F Zarreen, and DG. Harrison The central nervous system and inflammation in hypertension Curr. Opin. Pharmacol. 11 2011 156 161
42. HE Lob, PJ Marvar, TJ Guzik, S Sharma, LA McCann, C Weyand, FJ Gordon, and DG. Harrison Induction of hypertension and peripheral inflammation by reduction of extracellular superoxide dismutase in the central nervous system Hypertension 55 2010 277 283
43. CA Costa, TA Amaral, LC Carvalho, DT Ognibene, AF da Silva, MB Moss, SS Valenca, RS de Moura, and AC. Resende Antioxidant treatment with tempol and apocynin prevents endothelial dysfunction and development of renovascular hypertension Am. J. Hypertens. 22 2009 1242 1249
44. F Palm, M Onozato, WJ Welch, and CS. Wilcox Blood pressure, blood flow, and oxygenation in the clipped kidney of chronic 2-kidney, 1-clip rats: effects of tempol and angiotensin blockade Hypertension 55 2010 298 304
45. C Sun, KW Sellers, C Sumners, and MK. Raizada NAD(P)H oxidase inhibition attenuates neuronal chronotropic actions of angiotensin II Circ. Res. 96 2005 659 666 (Pubitemid 40478333)
46. VV Shuvaev, J Han, S Tliba, E Arguiri, M Christofidou-Solomidou, SH Ramirez, H Dykstra, Y Persidsky, DN Atochin, PL Huang, and VR. Muzykantov Anti-inflammatory effect of targeted delivery of SOD to endothelium: mechanism, synergism with NO donors and protective effects in vitro and in vivo PLoS One 8 2013 e77002
47. ED Hood, CF Greineder, C Dodia, J Han, C Mesaros, VV Shuvaev, IA Blair, AB Fisher, and VR. Muzykantov Antioxidant protection by PECAM-targeted delivery of a novel NADPH-oxidase inhibitor to the endothelium in vitro and in vivo J. Controlled Release 163 2012 161 169
48. MD Howard, CF Greineder, ED Hood, and VR. Muzykantov Endothelial targeting of liposomes encapsulating SOD/catalase mimetic EUK-134 alleviates acute pulmonary inflammation J. Controlled Release 177C 2014 34 41
49. ED Hood, M Chorny, CF Greineder, S Alferiev, I Levy, and RJ Muzykantov VR. Endothelial targeting of nanocarriers loaded with antioxidant enzymes for protection against vascular oxidative stress and inflammation Biomaterials 35 2014 3708 3715
50. VR. Muzykantov Targeting of superoxide dismutase and catalase to vascular endothelium J. Controlled Release 71 2001 1 21 (Pubitemid 32195437)
51. WT Godbey, KK Wu, and AG. Mikos Poly(ethylenimine)-mediated gene delivery affects endothelial cell function and viability Biomaterials 22 2001 471 480 (Pubitemid 32007852)
52. SM Moghimi, P Symonds, JC Murray, AC Hunter, G Debska, and A. Szewczyk A two-stage poly(ethylenimine)-mediated cytotoxicity: implications for gene transfer/therapy Mol. Ther. 11 2005 990 995 (Pubitemid 40724119)